|
1. |
Details of PDMR/person closely associated with them ('PCA') | ||
|
a) |
Name |
Dr K Slaoui | |
|
b) |
Position/status |
PCA of Dr M M Slaoui (Chairman, Global Vaccines) | |
|
c) |
Initial notification/
amendment |
Initial notification | |
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
|
a) |
Name |
GlaxoSmithKline plc | |
|
b) |
LEI |
5493000HZTVUYLO1D793 | |
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||
|
a) |
Description of the financial instrument |
GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
| |
|
b) |
Nature of the transaction |
An increase of 1 ADS following the notional allocation of ADSs on 8 August 2016, at a price of $44.41 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.
| |
|
c) |
Price(s) and
volume(s) |
Price(s) |
Volume(s) |
|
$44.41 |
1 | ||
|
d) |
Aggregated information
Aggregated volume Price |
n/a (single transaction) | |
|
e) |
Date of the transaction |
2016-08-08 | |
|
f) |
Place of the transaction
|
n/a
| |